510(k) K223602

Traumatic brain injury (TBI) test by Abbott Laboratories — Product Code QAT

K223602 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "Traumatic brain injury (TBI) test". The FDA issued a decision of Substantially Equivalent on Mar 2, 2023. The device falls under product code QAT (Brain Trauma Assessment Test), a Class II device regulated under 21 CFR 866.5830. Abbott Laboratories has 889 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 2, 2023
Date Received
Dec 2, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Brain Trauma Assessment Test
Device Class
Class II
Regulation Number
866.5830
Review Panel
IM
Submission Type
510(k)

Intended for in vitro diagnostic use as an aid in the evaluation of patients with suspected mild traumatic brain injury (TBI) in conjunction with other clinical information to assist in determining the need for radiologic (e.g., CT, MR) head imaging per current standard of care

Need the full FDA record for Abbott Laboratories? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K223602. Report a data issue: hello@regdatalab.com.